Literature DB >> 29856726

Interferon-gamma (IFN-γ): Exploring its implications in infectious diseases.

Gunjan Kak1, Mohsin Raza2, Brijendra K Tiwari1.   

Abstract

A key player in driving cellular immunity, IFN-γ is capable of orchestrating numerous protective functions to heighten immune responses in infections and cancers. It can exhibit its immunomodulatory effects by enhancing antigen processing and presentation, increasing leukocyte trafficking, inducing an anti-viral state, boosting the anti-microbial functions and affecting cellular proliferation and apoptosis. A complex interplay between immune cell activity and IFN-γ through coordinated integration of signals from other pathways involving cytokines and Pattern Recognition Receptors (PRRs) such as Interleukin (IL)-4, TNF-α, Lipopolysaccharide (LPS), Type-I Interferons (IFNS) etc. leads to initiation of a cascade of pro-inflammatory responses. Microarray data has unraveled numerous genes whose transcriptional regulation is influenced by IFN-γ. Consequently, IFN-γ stimulated cells display altered expression of many such target genes which mediate its downstream effector functions. The importance of IFN-γ is further reinforced by the fact that mice possessing disruptions in the IFN-γ gene or its receptor develop extreme susceptibility to infectious diseases and rapidly succumb to them. In this review, we attempt to elucidate the biological functions and physiological importance of this versatile cytokine. The functional implications of its biological activity in several infectious diseases and autoimmune pathologies are also discussed. As a counter strategy, many virulent pathogenic species have devised ways to thwart IFN-γ endowed immune-protection. Thus, IFN-γ mediated host-pathogen interactions are critical for our understanding of disease mechanisms and these aspects also manifest enormous therapeutic importance for the annulment of various infections and autoimmune conditions.

Entities:  

Keywords:  Cytokine; Cytokine therapy; Host-pathogen interaction; IFN-γ; Immune Response; Infectious Diseases; Mycobacteria

Mesh:

Substances:

Year:  2018        PMID: 29856726     DOI: 10.1515/bmc-2018-0007

Source DB:  PubMed          Journal:  Biomol Concepts        ISSN: 1868-5021


  80 in total

1.  Cytokines (IL-15, IL-21, and IFN-γ) in rheumatoid arthritis: association with positivity to autoantibodies (RF, anti-CCP, anti-MCV, and anti-PADI4) and clinical activity.

Authors:  Itzel Viridiana Reyes-Pérez; Pedro Ernesto Sánchez-Hernández; José Francisco Muñoz-Valle; Gloria Esther Martínez-Bonilla; Trinidad García-Iglesias; Verónica González-Díaz; Samuel García-Arellano; Sergio Cerpa-Cruz; Julissa Polanco-Cruz; María Guadalupe Ramírez-Dueñas
Journal:  Clin Rheumatol       Date:  2019-07-17       Impact factor: 2.980

2.  Designing a novel E2-IFN-γ fusion protein against CSFV by immunoinformatics and structural vaccinology approaches.

Authors:  Yanmin Zhang; Weijian Zhang; Jun Cheng; Xuping Liu; Shiwei Miao; Wen-Song Tan; Liang Zhao
Journal:  Appl Microbiol Biotechnol       Date:  2022-05-07       Impact factor: 4.813

Review 3.  Neuroinflammation and Proinflammatory Cytokines in Epileptogenesis.

Authors:  Alireza Soltani Khaboushan; Niloufar Yazdanpanah; Nima Rezaei
Journal:  Mol Neurobiol       Date:  2022-01-11       Impact factor: 5.590

Review 4.  Microglia in CNS infections: insights from Toxoplasma gondii and other pathogens.

Authors:  Maureen N Cowan; Ish Sethi; Tajie H Harris
Journal:  Trends Parasitol       Date:  2022-01-14

5.  The effects of phenanthrene exposure on Treg and Th17 cells related cytokines in female rats.

Authors:  Haitao Ma; Huizhen Guo; Wenwen Zhang; Fengjing Hu; Yushan Huang; Yong Zeng; Yang Liu; Chengyun Li; Junling Wang
Journal:  Toxicol Res (Camb)       Date:  2020-05-15       Impact factor: 3.524

Review 6.  Breast cancer resistance mechanisms: challenges to immunotherapy.

Authors:  Ann Hanna; Justin M Balko
Journal:  Breast Cancer Res Treat       Date:  2021-07-28       Impact factor: 4.872

7.  Downregulation of Interferon-γ Receptor Expression Endows Resistance to Anti-Programmed Death Protein 1 Therapy in Colorectal Cancer.

Authors:  Chunxiao Lv; Dongfen Yuan; Yanguang Cao
Journal:  J Pharmacol Exp Ther       Date:  2020-11-06       Impact factor: 4.030

Review 8.  Insights Into Host Cell Cytokines in Chlamydia Infection.

Authors:  Wenjing Xiang; Nanyan Yu; Aihua Lei; Xiaofang Li; Shui Tan; Lijun Huang; Zhou Zhou
Journal:  Front Immunol       Date:  2021-05-21       Impact factor: 7.561

Review 9.  Autoimmunity as an Etiological Factor of Cancer: The Transformative Potential of Chronic Type 2 Inflammation.

Authors:  Chris M Li; Zhibin Chen
Journal:  Front Cell Dev Biol       Date:  2021-06-21

10.  IL-21 Optimizes the CAR-T Cell Preparation Through Improving Lentivirus Mediated Transfection Efficiency of T Cells and Enhancing CAR-T Cell Cytotoxic Activities.

Authors:  Li Du; Yaru Nai; Meiying Shen; Tingting Li; Jingjing Huang; Xiaojian Han; Wang Wang; Da Pang; Aishun Jin
Journal:  Front Mol Biosci       Date:  2021-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.